RPRX
Royalty Pharma PlcNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$29.69B
P/E Ratio
28.14
EPS
$1.78
Beta
0.39
52W High
$50.47
52W Low
$31.23
50-Day MA
$47.24
200-Day MA
$40.48
Dividend Yield
1.78%
Profit Margin
32.40%
Forward P/E
30.77
PEG Ratio
2.87
About Royalty Pharma Plc
Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | $2.38B |
| Gross Profit (TTM) | $2.67B |
| EBITDA | $1.56B |
| Operating Margin | 57.70% |
| Return on Equity | 13.20% |
| Return on Assets | 5.15% |
| Revenue/Share (TTM) | $5.53 |
| Book Value | $15.11 |
| Price-to-Book | 3.44 |
| Price-to-Sales (TTM) | 12.49 |
| EV/Revenue | 12.5 |
| EV/EBITDA | 18.17 |
| Quarterly Earnings Growth (YoY) | 9.00% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $444.38M |
| Float | $420.22M |
| % Insiders | 7.12% |
| % Institutions | 84.58% |
Historical Volatility
HV 10-Day
19.03%
HV 20-Day
19.76%
HV 30-Day
21.32%
HV 60-Day
20.20%
HV Rank
46.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($52.44 target)
2
Strong Buy6
Buy2
HoldData last updated: 5/1/2026